An Integrated Multi-Faceted Knowledge Translation Intervention to Improve Bone Health in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

HomeResearchOur StudiesAn Integrated Multi-Faceted Knowledge Translation Intervention to Improve Bone Health in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

Men who have prostate cancer may get Androgen Deprivation Therapy (ADT), otherwise known as hormone therapy, as part of their treatment. ADT is a type of hormone therapy that can help slow tumor growth. A side effect of ADT may be loss of bone mineral density (BMD), which can lead to osteoporosis and bone fractures. To address bone loss in men receiving ADT, we developed a simple clinical intervention called “BoneRx”. This intervention BoneRx will be provided at the start of ADT and includes two parts: 1) a healthly bone prescription that reminds the doctor to order a BMD test and that provides clear advice to men on what they should do to protect their bones test; and 2) a booklet entitled “Building Strong Bones” which contains detailed information on how ADT affects bones and healthy bone behaviors.As part of a Canadian Cancer Society Research Institute funded study, we are currently implementing BoneRx into the Prostate site at Princess Margaret Cancer Centre. This study will begin by testing BoneRx with a small number of patients, to see how it can be rolled out as part of clinical care to all men who are receiving ADT.

Nour Alkazaz 416-581-7524 or nour.alkazaz@rmp.uhn.ca